Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy

Authors

Wataru Nakahara
Hidetoshi Satomi (ORCID: https://orcid.org/0000-0002-0400-280X)
Hiraku Murakami
Yasuhiro Shingai (ORCID: https://orcid.org/0000-0003-1017-4664)
Makiko Suga (ORCID: https://orcid.org/0009-0002-5487-1525)
Yoshiki Matsuoka
Takuya Terakawa
Jun Ishikawa (ORCID: https://orcid.org/0000-0002-2946-7988)
Sayako Yuda
Yuka Amemiya
Shigeo Fuji (ORCID: https://orcid.org/0000-0002-8088-6088)
Yuma Tada
Naoki Hosen
Takafumi Yokota
Seishi Ogawa
Yasuhito Nannya
Henyun Shi

Institutions

Osaka Gakuin University (JP)
Kyoto University (JP)
Osaka International Cancer Institute (JP)
Osaka International Cancer Institute (JP)
The University of Osaka (JP)

Publication Details

Journal: Haematologica
Published: 2025-12-24
DOI: https://doi.org/10.3324/haematol.2025.289269
Primary Topic: CAR-T cell therapy research
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Bristol-Myers Squibb
Eisai
Mitsubishi Foundation
Otsuka Pharmaceutical
Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
Novartis Pharma
Chugai Pharmaceutical

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy

Wataru Nakahara, Hidetoshi Satomi, Hiraku Murakami, Yasuhiro Shingai et al.

Dec 24, 2025

Haematologica

CAR-T cell therapy research

article

Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy

Wataru Nakahara, Hidetoshi Satomi, Hiraku Murakami, Yasuhiro Shingai, Makiko Suga, Yoshiki Matsuoka, Takuya Terakawa, Jun Ishikawa, Sayako Yuda, Yuka Amemiya, Shigeo Fuji, Yuma Tada, Naoki Hosen, Takafumi Yokota, Seishi Ogawa, Yasuhito Nannya, Henyun Shi

December 24, 2025article en

Abstract

No abstract available for this paper.

Haematologica

Osaka Gakuin University (JP), Kyoto University (JP), Osaka International Cancer Institute (JP), Osaka International Cancer Institute (JP), The University of Osaka (JP)

Bristol-Myers Squibb, Eisai, Mitsubishi Foundation, Otsuka Pharmaceutical, Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, Novartis Pharma, Chugai Pharmaceutical

Openalex Percentile: Top 31%

CAR-T cell therapy research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Secondary T-cell lymphoma arising from pre-existing clones in a patient with diffuse large B-cell lymphoma during epcoritamab treatment following CAR-T therapy — Wataru Nakahara, Hidetoshi Satomi, et al. · Haematologica (2025) | TGRS Research Map | TGRS